Viewsml raised $4.9M | Health

Website https://www.viewsml.com

HQ Country 🌍 N/A

Careers Jobs ↗

LinkedIn —

Track Viewsml — get Health deals in free daily digest

Overview

Viewsml has raised $4.9 million in an oversubscribed seed funding round to accelerate the commercialization of its AI-powered virtual biomarker staining platform. The round was led by Wittington Ventures, with participation from Continuum Health Ventures, Mayo Clinic, and other existing investors.

Products

Recent Deals

ViewsML: $4.9 Million Seed Funding Raised To Commercialize AI-Powered Virtual Biomarker Staining Platform

$4.9M

Investors: Wittington Ventures, Continuum Health Ventures, Mayo Clinic

ViewsML: $4.9 Million Seed Funding Raised To Commercialize AI-Powered Virtual Biomarker Staining Platform (Pulse2)

More Health Deals

Company		Deal	Headline	Date
Bioxtreme	🌍	$15M	Bioxtreme: Strategic Investment From Serra Holding And Plaxtreme Launch Advance Neurorehabilitation Robotics Serra Holding	23 Apr 2026
Courier Health	🇺🇸	$50M	Courier Health: $50 Million Series B Fuels AI-Driven Patient Experience Platform For Biopharma Oak HC/FT, Norwest, Work-Bench	22 Apr 2026
Amperos Health	🇺🇸	$16M	Amperos Health: $16 Million Series A Funds AI-Driven Denial Management Platform Launch Bessemer Venture Partners, Uncork Capital, Neo	22 Apr 2026
Calibre	🇬🇧	$3.024M	Uk HealthTech Startup Calibre Raises €2.8M Funding In Pre-Seed Round Amino Collective, Daybreak Ventures, Cocoa Ventures, Timo Boldt, Maximilian Tayenthal	22 Apr 2026
Arlo Technologies	🇺🇸	—	Arlo Technologies: Acquisition Of Aloe Care Health Expands AI-Powered Platform Into Aging-In-Place Care	20 Apr 2026
Coral	🇺🇸	$12.5M	Coral raises $12.5M for healthcare automation Lightspeed,Z47	20 Apr 2026
Alloy Therapeutics	🇺🇸	$40M	Alloy Therapeutics: $40 Million Series E At $1 Billion Valuation Raised To Scale AI-Driven Biotech Infrastructure 8VC, JIC Venture Growth Investments, Echo Capital, Mubadala Capital, Thiel Capital	19 Apr 2026
Biolamina	🇸🇪	$21.6M	Stockholm’s BioLamina Raises €20M EIB Loan To Scale Cell Therapy Development	17 Apr 2026
Deepcyte	🇩🇰	$1.5M	DeepCyte: $1.5 Million Seed Funding Launches AI-Powered Single-Cell Toxicology Platform	14 Apr 2026
Annovis Bio	🇺🇸	$10M	Annovis Bio Raises $10M to Fund Alzheimer’s Phase 3 Through NDA Filing Michael Hoffman	10 Apr 2026

See all Health deals → 📈 Advanced Deal Explorer → 🏆 Investor Rankings →

Daily Intelligence

Get the next deal before everyone else.

30+ AI funding deals, every weekday morning.

✓ You're in. First edition lands tomorrow morning.

No spam. Unsubscribe any time.

Market Map

View thousands of companies by category in our market map: